Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lamb

Showing results (31-40 of 244) with videos related to

Pageof 25
Sort By:
Drugs|May 14, 2022
Pacritinib: First ApprovalYvette N Lamb
Clinics in Laboratory Medicine|November 29, 2011
Laboratory aspects of prenatal microarray analysisAllen N Lamb
Drugs|August 19, 2017
Inotuzumab Ozogamicin: First Global ApprovalYvette N Lamb
Drugs|November 16, 2018
Correction to: Elagolix: First Global ApprovalYvette N Lamb
Drugs|July 5, 2024
Givinostat: First ApprovalYvette N Lamb
Drugs|March 1, 2020
Correction to: Pexidartinib: First ApprovalYvette N Lamb
Drugs|September 16, 2020
Daratumumab: A Review in Combination Therapy for Transplant-Eligible Newly Diagnosed Multiple MyelomaYvette N Lamb
Clinical Drug Investigation|October 2, 2019
Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its UseYvette N Lamb
Drugs|February 23, 2021
Inclisiran: First ApprovalYvette N Lamb
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 26, 2018
SB3 (Ontruzant<sup>®</sup>): A Trastuzumab BiosimilarYvette N Lamb
Pageof 25

Showing results (31-40 of 244) with videos related to

Sort By:
Pageof 25
Drugs|May 14, 2022
Pacritinib: First ApprovalYvette N Lamb
Clinics in Laboratory Medicine|November 29, 2011
Laboratory aspects of prenatal microarray analysisAllen N Lamb
Drugs|August 19, 2017
Inotuzumab Ozogamicin: First Global ApprovalYvette N Lamb
Drugs|November 16, 2018
Correction to: Elagolix: First Global ApprovalYvette N Lamb
Drugs|July 5, 2024
Givinostat: First ApprovalYvette N Lamb
Drugs|March 1, 2020
Correction to: Pexidartinib: First ApprovalYvette N Lamb
Drugs|September 16, 2020
Daratumumab: A Review in Combination Therapy for Transplant-Eligible Newly Diagnosed Multiple MyelomaYvette N Lamb
Clinical Drug Investigation|October 2, 2019
Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its UseYvette N Lamb
Drugs|February 23, 2021
Inclisiran: First ApprovalYvette N Lamb
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 26, 2018
SB3 (Ontruzant<sup>®</sup>): A Trastuzumab BiosimilarYvette N Lamb
Pageof 25